• Jun 2017, presentation of the non-clinical results of brain tumors at the 4th Association of Regenerative Medicine Symposium held in Tokyo, Japan
  • Apr 2017, patent application for a method of mass propagation of natural killer cells (10-2017-0050837, PCT/KR2017005571)
  • Feb 2017, patent application for unmanned sterile automatic cell culture device (10-2017-0023379)
  • Dec 2016, patent application for large-scale proliferation and activation of NK cells using macrophages, etc. (10-2016-0168274, PCT/KR2016/014502)
  • Development of a high-proportion NK cell and high-dose immune cell culture method
  • Mar 2016, establishment of Imunis Biotech Co., Ltd.